Assessment of clinical pharmacists' interventions in French Hospitals: Results of a multicenter study

Annals of Pharmacotherapy

Volumn 42, Issue 7-8, 2008, Pages 1095-1103

  Bedouch, Pierrick ^a   Charpiat, Bruno ^b   Conort, Ornella ^c   Rose, François Xavier ^d   Escofier, Laurence ^e   Juste, Michel ^f   Roubille, Renaud ^g   Allenet, Benoît ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CROIX ROUSSE HOSPITAL   (France)

^c Assistance Publique des Hôpitaux de Paris ^*  (France)

^d Hotel Dieu CHU Rennes   (France)

^e Centre Hospitalier de Mayenne   (France)

^f Centre Hospitalier Auban Moet   (France)

^g Centre Hospitalier Lucien Hussel   (France)

Author keywords

Clinical pharmacy; Drug related problems; France; Pharmacoepidemiology

Indexed keywords

ALPRAZOLAM; ANALGESIC AGENT; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CARDIOVASCULAR AGENT; COLECALCIFEROL; DEXTROPROPOXYPHENE; ENOXAPARIN; FERROUS FUMARATE; FLUOXETINE; GASTROINTESTINAL AGENT; GLICLAZIDE; HALOPERIDOL; HYDROXYZINE; NICARDIPINE; OFLOXACIN; OMEPRAZOLE; PARACETAMOL; PAROXETINE; PSYCHOTROPIC AGENT; RISPERIDONE; TRAMADOL; UNINDEXED DRUG; VALPROIC ACID; ZOLPIDEM; ZOPICLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PHARMACY; CLINICAL TRIAL; DEMOGRAPHY; DRUG MONITORING; EUROPE; FEMALE; FRANCE; HOSPITAL PHARMACY; HUMAN; MALE; MULTICENTER STUDY; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; VALIDATION PROCESS; WARD;

FRANCE; INTERPROFESSIONAL RELATIONS; MEDICATION ERRORS; PHARMACISTS; PHARMACOEPIDEMIOLOGY; PHARMACY SERVICE, HOSPITAL; PHYSICIANS; PRESCRIPTIONS, DRUG; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE;

EID: 48249113268     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L045     Document Type: Article

References (28)

1. Kohn LT, Corrigan JM, Donaldson MS, et al. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999.
2. Aspden P, Wolcott J, Bootman JL, et al. Preventing medication errors: quality chasm series. Washington, DC: National Academy Press, 2006.
3. van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859-67. Epub 30 Mar 2004. DOI 10.1345/aph.1D182
4. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997; 54:554-8.
5. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
6. Michel P, Quenon JL, Djihoud A, Tricaud-Vialle S, de Sarasqueta AM. French national survey of inpatient adverse events prospectively assessed with ward staff. Qual Saf Health Care 2007;16:369-77. DOI 10.1136/qshc.2005.016964
7. LeBlanc JM, Dasta JF. Scope of international hospital pharmacy practice. Ann Pharmacother 2005;39:183-91. Epub 14 Dec 2004. DOI 10.1345/aph.1E317
8. Dooley MJ, Allen KM, Doecke CJ, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 2004;57:513-21. DOI 10.1046/j.365-2125.003.02029.x
9. Guignon AM, Grain F, Allenet B, et al. [Assessment of the clinical impact of pharmacists' recommendations in a medical care unit] French. J Pharm Clin 2001;20:118-23.
10. Bedouch P, Allenet B, Labarere J, et al. [Diffusion of pharmacist interventions within the framework of clinical pharmacy activity in clinical ward] French. Therapie 2005;60:515-22.
11. Vernardet S, Bossaert S, Livrozet A, Pont E, Charpiat B. [Pharmaceutical analysis and validation of hospital prescriptions, a 5-year study] French. Presse Med 2005;34:990-6.
12. Allenet B, Bedouch P, Rose FX, et al. Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci 2006;28:181-8. DOI 10.1007/s11096-006-9027-5
13. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990;24:1093-7.
14. Viktil KK, Blix HS, Reikvam A, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother 2004;38:942-8. Epub 6 Apr 2004. DOI 10.1345/aph.1D531
15. Schmidt IK, Claesson CB, Westerholm B, Nilsson LG. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998;32:27-32.
16. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995;10:199-205.
17. Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. A 9-year experience. Arch Intern Med 1997;157:1569-76.
18. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
19. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8. DOI 10.1001/archinte.163.17. 2014
20. Alderman CP, Farmer C. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract 2001;21:99-103.
21. Barber ND, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 1997;54:397-405.
22. Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004;60:651-8. DOI 10.1007/s00228-004-0830-4
23. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003;60:1750-9.
24. Hendrickson JR, North DS. Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil. Ann Pharmacother 1995;29:561-5.
25. Roughead EE. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract 1999;19:19-22.
26. Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium - description of the impact on a geriatric unit. Ann Pharmacother 2006;40: 720-8. Epub 28 Mar 2006. DOI 10.1345/aph.1G515
27. Bedouch P, Charpiat B, Roubille R, et al. [The French Society of Clinical Pharmacy website for the documentation and analysis of pharmacist's interventions: purpose, instructions and perspectives] French. J Pharm Clin 2007;26:40-4. DOI 10.1684/jpc.2007.0027
28. Simonian AI. Documenting pharmacist interventions on an intranet. Am J Health Syst Pharm 2003;60:151-5.